For the complete documentation index, see /llms.txt. The full corpus is available at /llms-full.txt. Most pages have a raw markdown variant; append .md to the URL or send Accept: text/markdown.
Try out Invert Assist free.Try Assist

Blog

Insights from the Invert team.

Perspectives on bioprocess data, AI in biomanufacturing, and building the intelligence layer for biopharma teams.

IndustryNovember 9, 2026

A bioprocess digital twin needs live data

Will Olughu explains why a bioprocess digital twin needs live data, how to plan the data architecture, and what sponsors should agree with CDMOs.

Read article
What is Cpk, and how do biologics teams use it?
IndustrySeptember 29, 2026

What is Cpk, and how do biologics teams use it?

Cpk, the process capability index, measures how well a stable process fits inside its specification limits. This guide covers the formula, a worked example, Cpk vs Ppk, what counts as a good Cpk, and why capability is harder to read for biologics.

Read article
What is OPC UA, and how do bioreactors use it?
IndustrySeptember 14, 2026

What is OPC UA, and how do bioreactors use it?

OPC UA is the vendor-neutral standard bioprocess equipment uses to publish live process data. What it is, how it differs from OPC DA and MQTT, which bioreactors speak it, and how Invert uses it, with the other interfaces your systems expose, to bring every signal into one place as the run happens.

Read article
IndustryDecember 2, 2025

The Bioprocess Scale-Up Playbook: From Fragmented Data to Confident Decisions

Learn how leading pharma, biologics, and vaccine teams close the scale-up gap with unified data, real-time visibility, and a built-in bioprocess intelligence layer. See how Invert transforms fragmented bioprocess data into faster, more confident decisions across development and manufacturing.

Read article
AI in Bioprocess Quality Control: Moving from Compliance to Confidence
IndustryNovember 17, 2025

AI in Bioprocess Quality Control: Moving from Compliance to Confidence

Learn how AI powered bioprocess quality control software helps pharma and cell therapy manufacturers improve consistency, strengthen GxP compliance, and shift from reactive oversight to confident, real time decision making.

Read article
Best Practices for Bioprocess Data Integration
IndustryNovember 17, 2025

Best Practices for Bioprocess Data Integration

Learn the key best practices for integrating bioprocess data across development, scale up, CDMOs, and manufacturing. Discover how harmonized, contextualized, AI ready data accelerates insight and reduces risk.

Read article
How to Scale Up Bioprocess Manufacturing Without the Data Headaches
IndustryNovember 17, 2025

How to Scale Up Bioprocess Manufacturing Without the Data Headaches

Learn how bioprocess teams are scaling manufacturing faster with AI-powered intelligence platforms that unify data, simplify tech transfer, and reduce risk in cell therapy and pharmaceutical production.

Read article
Top AI Tools Powering Biomanufacturing (2026 Edition)
IndustryNovember 11, 2025

Top AI Tools Powering Biomanufacturing (2026 Edition)

A 2026 guide to AI tools for biomanufacturing: what to look for in bioprocess AI software and manufacturing intelligence, five platforms, and vendor questions.

Read article
What Is Bioprocess AI? How Artificial Intelligence Is Transforming Manufacturing Intelligence
IndustryNovember 11, 2025

What Is Bioprocess AI? How Artificial Intelligence Is Transforming Manufacturing Intelligence

Learn how Bioprocess AI software unifies data, accelerates decision-making, and drives faster scale-up in biomanufacturing. Discover why the next wave of manufacturing intelligence starts with live, trusted data.

Read article
Why Bioprocess Data Fragmentation Is Slowing Down the Industry
IndustryNovember 11, 2025

Why Bioprocess Data Fragmentation Is Slowing Down the Industry

Learn how fragmented bioprocess data creates risk, waste, and delays, and how an AI-ready data foundation helps unify insights, accelerate scale-up, and improve manufacturing outcomes.

Read article
AI That Bioprocess Teams Can Trust: Highlights from BioTalk Berlin
IndustryNovember 5, 2025

AI That Bioprocess Teams Can Trust: Highlights from BioTalk Berlin

Recorded live at BioTalk Berlin on September 18, 2025 — featuring Michael McCutchen, Senior Product Manager at Invert. Scroll to the end to watch the full talk.

Read article
The Best Real-Time Bioprocess Monitoring Platform for Biomanufacturing
IndustryNovember 5, 2025

The Best Real-Time Bioprocess Monitoring Platform for Biomanufacturing

See why Invert is the best real-time bioprocess monitoring platform for pharmaceutical manufacturing and scale-up. Live data, AI insights, compliance-ready.

Read article
7 Best AI Bioprocess Optimization Platforms for Pharmaceutical Manufacturing in 2026
IndustryNovember 4, 2025

7 Best AI Bioprocess Optimization Platforms for Pharmaceutical Manufacturing in 2026

Seven AI platforms and bioprocessing software tools for bioprocess optimization in pharmaceutical manufacturing in 2026: what each one does, where it fits, and how to choose. BCC Research (Dec 2024) puts the market at $24.3B in 2024, growing to $39.6B by 2029.

Read article
Best Bioprocess Data Integration Platforms for Pharma in 2026
IndustryNovember 4, 2025

Best Bioprocess Data Integration Platforms for Pharma in 2026

Compare six platforms that connect some or all of your bioreactors, historians, LIMS, and ELN, plus what to check before you choose.

Read article
A Guide to Build vs Buy: Biotech Software Edition
IndustryJanuary 12, 2025

A Guide to Build vs Buy: Biotech Software Edition

For biotech and synthetic biology companies, there’s always A LOT of work to do. As these companies quickly learn, trying to handle everything in-house–from strain design and high-throughput screening to process development and beyond–can spread funding and resources thinly.

Read article
Bioprocess Tech Transfer: Navigating The Data Dilemma
IndustryJanuary 12, 2025

Bioprocess Tech Transfer: Navigating The Data Dilemma

The transfer of institutional data and knowledge is critical to the development of biotechnologies, bioproducts, and biotherapeutics.

Read article
Why Have Bioprocess Data Solutions Been Overlooked…Until Now?
IndustryJanuary 12, 2025

Why Have Bioprocess Data Solutions Been Overlooked…Until Now?

Given the glaring challenge of managing bioprocess data, the question remains: Why have bioprocess data solutions been historically overlooked?

Read article